About drug dialyzability

Acta Clinica Croatica

Volumn 42, Issue 3, 2003, Pages 257-267

  Šefer, Siniša ^a   Degoricija, Vesna ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Dialysis solutions, pharmacokinetics; Kidney failure, therapy; Peritoneal dialysis; Pharmaceutical preparations, administration, and dosage; Renal dialysis, trends; Renal replacement therapy, methods

Indexed keywords

ABCIXIMAB; ACARBOSE; ACETAZOLAMIDE; ACETIC ACID; ACETYLSALICYLIC ACID; ACICLOVIR; ALBENDAZOLE; ALBUMIN; ALENDRONIC ACID; ALLOPURINOL; ALPRAZOLAM; ALTEPLASE; AMANTADINE; AMIFOSTINE; AMIKACIN; AMILORIDE; AMINOCAPROIC ACID; AMINOGLUTETHIMIDE; AMINOSALICYLIC ACID; AMIODARONE; AMITRIPTYLINE; AMLODIPINE; AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; ANASTROZOLE; ETRETIN; PARACETAMOL; PROSTAGLANDIN E1; UNINDEXED DRUG;

BINDING AFFINITY; BINDING KINETICS; BLOOD FLOW VELOCITY; DIALYSIS MEMBRANE; DRUG BIOAVAILABILITY; DRUG DIALYSABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG SOLUBILITY; ERYTHROCYTE; HEMOFILTRATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MOLECULAR WEIGHT; PERITONEAL DIALYSIS; PLASMA CLEARANCE; PRESCRIPTION; REVIEW; SURFACE PROPERTY;

EID: 0348108085     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. BRUNNER H, MANN H, STILLER S, SIEBERTH HG. Permeability for middle and higher molecular weight substances. Contrib Nephrol 1985;46:33-42.
2. LASRICH M, MAHER JM, HIRSZEL P, MAHER JF. Correlation of peritoneal transport rates with molecular weight: a method of predicting clearance. ASAIO 1979;2:107-13.
3. McNAMARA PJ, LALKA D, GIBALDI M. Endogenous accumulation products and serum protein binding in uremia. J Lab Clin Med 1981;98:730-40.
4. LEVY G. Pharmacokinetics in renal disease. Am J Med 1977;62:461-5.
5. REIDENBERG MM. The biotransformation of drugs in renal failure. Am J Med 1977;62:482-5.
6. PIAFSKY KM. Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 1980;5:246-62.
7. RUSTEIN DD, CATELLI WP, NICKERSON RJ. Heparin and human lipid metabolism. Lancet 1969;2:1003-11.
8. SUFI B, CRAIG WA, ENGLAND AC, ELLIOT RL. Effect of free fatty acids on protein binding of antimicrobial agents. J Infect Dis 1981;143:609-16.
9. GOLPER TA, MARX MA, SHULER C, BENNETT WM. Drug dosage in dialysis patients. In: JACOBS C, KJELLSTAND CM, KOCH KM, WINCHESTER JF, eds. Replacement of renal function by dialysis. Dordrecht, the Netherlands: Kluwer Academic Publichers, 1996:619-56.
10. MARBURY TC, LEE CC, PERCHALSKI RJ, WILDER BJ. Hemodialysis clearance of ethosuximide in patients with chronic renal disease. Am J Hosp Pharm 1981;38:1757-60.
11. LEE CS, MARBURY TC, BENET LZ. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol. J Pharmacokinet Biopharm 1980;8:69-81.
12. LEE CC, MARBURY TC. Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations. Clin Clin Pharmacokinet 1984;9:42-66.
13. KELLER F, WILLIAMS H, SCHULTZE G. Effect of plasma protein binding, volume of distribution, and molecular weight on the fraction of drug eliminated by hemodialysis. Clin Nephrol 1983;19:201-5.
14. MATZKE GR, O'CONNELL MB, COLLINS AJ, KESJAVIAH PR. Disposition of vankomycin during hemofiltration. Clin Pharmacol Ther 1986;40:425-30.
15. MAHER JP. Principles of dialysis and dialysis of drugs. Am J Med 1977;62:475-81.
16. BASTANI R, SPYKER SA, MINOCHA A. In rive comparison of three different hemodialysis membranes for vankomycin clearance: cuprofane, cellulose acetate, and polyacrylonitrile. Dial Transplant 1988;17:527.
17. JINDAL K, McDOUGALL J, GOLDESTEIN M. High-flux dialyzers: impact of ultrafiltration and surface area on clearance of small and large molecular weight substances, abstracted. Natl Kidney Found. Annu Mtg Abstr 1987;A10.
18. RUMPF KW, RIEGER J, DOHT B, ANSONG R, SCHELER F. Drug elimination by hemofiltration. J Dial 1977;1:677-8.
19. RUMPF KW, RIEGER J, ANSOG R. Binding of antibiotics by dialysis membranes and its clinical relevance. Proc Eur Dial Transplant 1978;14:607-9.
20. BOSCH T, SCHMIDT B, SAMTLEBEN W, GURLAND HJ. Effect of protein adsorption on diffusive and convective transport through polysulfone membranes. Contrib Nephrol 1985;46:14-22.
21. Von ALBERTINI B, MILLER JH, GARDNER PW, SHINABERGER JH. Performance characteristics of high-flux haemodiafiltration. Proc Eur Dial Transplant 1985;21:447-53.
22. GIBSON TP. Problems in designing hemodialysis drug studies. Pharmacotherapy 1985;5:23-9.
23. TAYLOR CA, ABDEL-RAHMAN E, ZIMMERMAN SW, JOHNSON CA. Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacokinet 1996;31:293-308.
24. KES P. High flow dialyzers. Lijec Vjesn 2002;124:50-1.
25. MATZKE GR. Pharmacotherapeutic consequences of recent advances in hemodialysis therapy. Ann Pharmacother 1994;28:512-4.
26. BELLOMO R, RONCO C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999;25:781-9.
27. GOLPER TA, MARX MA. Drug dosing adjustment during continuous renal replacement therapies. Kidney Int Suppl 1998;66:165-8.
28. BRESSOLLE F, KINOWSKI JM, de la COUSSAYE JE, WYNN N, ELEDJAM JJ, GALTIER M. Clinical pharmacokinetics during continuous hemofiltration. Clin Pharmacokinet 1994;26:457-71.
29. SUBACH RA, MARX MA. Drug dosing in acute renal failure: the role of renal replacement therapy in altering drug pharmacokinetics. Adv Ren Replace Ther 1998;5:141-7.
30. SCHETZ M, FERDINANDE P, Van den BERGHE G, VERWAEST C, LAUWERS P. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 1995;21:612-20.
31. JOY MS, MATZKE GR, ARMSTRONG DK, MARX MA, ZAROWITZ BJ. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998;32:362-75.
32. BROPHY DF, MUELLER BA. Automated peritoneal dialysis: new implications for pharmacists. Ann Pharmacother 1997;31:756-64.
33. BROPHY DE, SOWINSKI KM, KRAUS MA, MOE SM, KLAUNIG JE, MUELLER BA. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis. Perit Dial Int 1999;19:534-9.
34. DIAZ-BUXO JA, CRAWFORD TL, BAILIE GR. Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics. Petit Dial Int 2001;21:197-201.